Meeting
2019 ASCO Annual Meeting
Aspirin as adjuvant treatment for colorectal cancer: Rationale and progress of the Add-Aspirin trial.
Authors
Ruth E Langley
Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom
Ruth E Langley , Richard H. Wilson , Fay Helen Cafferty , Nalinie Joharatnam , Janet Shirley Graham , Daniel Swinson , Timothy Iveson , Farhat Vanessa Nasim Din , Robert J.C. Steele , Verity Henson , Anne Crossley , C S. Pramesh , Axel Walther , Richard Adams , Lesley K. Dawson , Roshan Agarwal , Komel Khabra , Mahesh K B Parmar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Local-Regional Disease
Clinical Trial Registration Number
74358648
Citation
J Clin Oncol 37, 2019 (suppl; abstr TPS3624)
DOI
10.1200/JCO.2019.37.15_suppl.TPS3624
Abstract #
TPS3624
Poster Bd #
111b
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Evaluating intermittent dosing of aspirin for colorectal cancer prevention.
First Author: Katrina M. Alber
Poster
2020 ASCO Virtual Scientific Program
Green tea extract to prevent colorectal adenomas in men and women: Results of the MIRACLE trial.
First Author: Thomas Jens Ettrich
Poster
2014 ASCO Annual Meeting
Add-Aspirin trial: A phase III, double blind, placebo-controlled, randomized trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common nonmetastatic solid tumors.
First Author: Ruth E Langley
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Comparative genomic analysis to identify a signature of sporadic colorectal cancer development in young adults.
First Author: Abedalrhman Alkhateeb